Mon, June 25, 2018
Fri, June 22, 2018
Thu, June 21, 2018
Wed, June 20, 2018
Tue, June 19, 2018
Mon, June 18, 2018
Fri, June 15, 2018
Thu, June 14, 2018
Wed, June 13, 2018
Tue, June 12, 2018
Mon, June 11, 2018
Fri, June 8, 2018
Thu, June 7, 2018
Wed, June 6, 2018
Tue, June 5, 2018
Mon, June 4, 2018
Fri, June 1, 2018
Thu, May 31, 2018
Wed, May 30, 2018
Tue, May 29, 2018

David Toung Maintained (ABBV) at Strong Buy with Decreased Target to $130 on, Jun 11th, 2018


//stocks-investing.news-articles.net/content/201 .. th-decreased-target-to-130-on-jun-11th-2018.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


David Toung of Argus Research, Maintained "AbbVie Inc." (ABBV) at Strong Buy with Decreased Target from $145 to $130 on, Jun 11th, 2018.

David has made no other calls on ABBV in the last 4 months.



There are 3 other peers that have a rating on ABBV. Out of the 3 peers that are also analyzing ABBV, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Geoff Meacham of "Barclays" Maintained at Hold with Decreased Target to $102 on, Thursday, April 5th, 2018


These are the ratings of the 2 analyists that currently disagree with David


  • Vamil Divan of "Credit Suisse" Downgraded from Hold to Sell and Decreased Target to $89 on, Wednesday, May 30th, 2018
  • Alex Arfaei of "BMO Capital" Maintained at Sell with Decreased Target to $78 on, Wednesday, May 23rd, 2018

Publication Contributing Sources